ArticleFrontiers in immunology2025

Integrative bioinformatics and experimental validation unveil CRISP3 as a hypoxia-, epithelial mesenchymal transition-, and immune-related prognostic biomarker and therapeutic target in breast cancer.

Yuanyuan Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.